Am J Perinatol 2022; 29(14): 1548-1554
DOI: 10.1055/s-0041-1722944
Original Article

Cord-Blood High-Sensitivity Troponin-I Reference Interval and Association with Early Neonatal Outcomes

Tapas Mondal*
1   Department of Pediatrics, McMaster Children's Hospital, Hamilton, Ontario, Canada
,
Paul M. Ryan*
2   Brookfield School of Medicine and Health Sciences, University College Cork, Cork, Ireland
,
Kaaran Gupta
1   Department of Pediatrics, McMaster Children's Hospital, Hamilton, Ontario, Canada
,
George Radovanovic
1   Department of Pediatrics, McMaster Children's Hospital, Hamilton, Ontario, Canada
,
Edward Pugh
1   Department of Pediatrics, McMaster Children's Hospital, Hamilton, Ontario, Canada
,
Anthony K. C. Chan
1   Department of Pediatrics, McMaster Children's Hospital, Hamilton, Ontario, Canada
,
Stephen Hill
3   Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
4   Laboratory Medicine, Hamilton Regional Laboratory Medicine Program, Hamilton, Ontario, Canada
› Author Affiliations
Funding No extramural funding was sought for this study. Reagents were provided as a grant-in-aid by Abbott Diagnostics, Canada. However, Abbott Diagnostics played no role in study design or implementation, data analysis, or preparation of the manuscript.

Abstract

Objective This study was aimed to establish a reference interval for high-sensitivity cardiac troponin I (hs-cTnI) in umbilical cord blood of infants and to assess its association with the risk of predetermined early neonatal outcomes in a high-acuity tertiary care hospital.

Study Design Umbilical cord-blood samples were collected and hs-cTnI was measured in all infants born between August 2015 and September 2015 at McMaster Children's Hospital (n = 256). Gestational age, birth weight, Apgar's scores, age in days at which feeding was established, neonatal intensive care unit (NICU) admission, and discharge in days after birth were recorded.

Results The 90th, 95th, and 99th percentiles for the term infant subcohort were 19.75, 41.45, and 166.30 ng/L, respectively. We observed decreased mean gestational ages and birth weights in both the 90th (37.7 weeks; 2,961.4 g) and 95th percentiles (37.1 weeks; 2,709.9 g) when compared with the remaining infants. Moreover, levels of hs-cTnI were significantly higher in infants with respiratory distress requiring intervention (p < 0.05), low birth weight infants (p < 0.01), preterm infants (p < 0.001), and those requiring NICU admission (p < 0.01). Multiple linear regression of the recorded demographic factors revealed prematurity (gestational age <35 weeks: coefficient 0.346 ± 0.160, p < 0.05; gestational age <37 weeks: coefficient 0.253 ± 0.105, p < 0.05) and male sex (coefficient 0.138 ± 0.047; p < 0.01) to be most predictive of log-hs-cTnI levels.

Conclusion This study establishes the reference values for cord-blood hs-cTnI in infants at a tertiary care center. Premature and sick infants requiring NICU admission had significantly higher levels of hs-cTnI.

Key Points

  • Established the 90th, 95th, and 99th percentiles of neonatal cord-blood hs-cTnI in term infants as 19.75, 41.45, and 166.30 ng/L, respectively.

  • Infants with hs-cTnI levels exceeding the 90th percentile had lower gestational ages and birth weights with higher rates of NICU admissions.

  • Infants with respiratory distress or requiring NICU admission were found to have higher levels of hs-cTnI.

* Co–first authorship: These authors contributed equally to this manuscript.




Publication History

Received: 19 April 2020

Accepted: 18 December 2020

Article published online:
06 February 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Dong WJ, Xing J, Robinson JM, Cheung HC. Ca(2+) induces an extended conformation of the inhibitory region of troponin I in cardiac muscle troponin. J Mol Biol 2001; 314 (01) 51-61
  • 2 Papneja K, Chan AK, Mondal TK, Paes B. Myocardial infarction in neonates: a review of an entity with significant morbidity and mortality. Pediatr Cardiol 2017; 38 (03) 427-441
  • 3 Reichlin T, Hochholzer W, Bassetti S. et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009; 361 (09) 858-867
  • 4 Turrini I, Sorbi F, Ghizzoni V. et al. Severe fetal distress and placental damage might be associated with high troponin I (cTnI) levels in mothers. Am J Case Rep 2018; 19: 194-198
  • 5 Baum H, Hinze A, Bartels P, Neumeier D. Reference values for cardiac troponins T and I in healthy neonates. Clin Biochem 2004; 37 (12) 1079-1082
  • 6 Subramanian S, Agarwal R, Deorari AK, Paul VK, Bagga A. Acute renal failure in neonates. Indian J Pediatr 2008; 75 (04) 385-391
  • 7 Almeida CM, Carrapato MR, Pinto F. et al. Biochemical markers of neonatal myocardial dysfunction. J Matern Fetal Neonatal Med 2011; 24 (04) 568-573
  • 8 Caselli C, Cangemi G, Masotti S. et al. Plasma cardiac troponin I concentrations in healthy neonates, children and adolescents measured with a high sensitive immunoassay method: High sensitive troponin I in pediatric age. Clin Chim Acta 2016; 458: 68-71
  • 9 Szymankiewicz M, Matuszczak-Wleklak M, Vidyasagar D, Gadzinowski J. Retrospective diagnosis of hypoxic myocardial injury in premature newborns. J Perinat Med 2006; 34 (03) 220-225
  • 10 Shiva R, Maryam R, Hajie B. Cardiac troponin T levels of umbilical cord in neonates with abnormal fetal heart rate. Iran J Pediatr 2013; 23 (01) 85-88
  • 11 Jehlicka P, Huml M, Rajdl D. et al. How to interpret elevated plasmatic level of high-sensitive troponin T in newborns and infants?. Physiol Res 2018; 67 (02) 191-195
  • 12 Trevisanuto D, Pitton M, Doglioni N. et al. Cord blood cardiac troponin T and troponin I levels in multiple-gestation neonates. Biol Neonate 2004; 85 (04) 269-272
  • 13 Keller T, Zeller T, Ojeda F. et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011; 306 (24) 2684-2693
  • 14 Awada H, Al-Tannir M, Ziade MF, Alameh J, El Rajab M. Cardiac troponin T: a useful early marker for cardiac and respiratory dysfunction in neonates. Neonatology 2007; 92 (02) 105-110
  • 15 Elkayam U, Akhter MW, Singh H. et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005; 111 (16) 2050-2055
  • 16 Siu SC, Sermer M, Colman JM. et al; Cardiac Disease in Pregnancy (CARPREG) Investigators. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001; 104 (05) 515-521
  • 17 Lipshultz SE, Simbre II VC, Hart S. et al. Frequency of elevations in markers of cardiomyocyte damage in otherwise healthy newborns. Am J Cardiol 2008; 102 (06) 761-766
  • 18 Nageh T, Sherwood RA, Harris BM, Thomas MR. Cardiac troponin I for risk stratification following percutaneous coronary artery intervention in acute coronary syndromes. Catheter Cardiovasc Interv 2002; 55 (01) 37-42
  • 19 Sweetman D, Armstrong K, Murphy JF, Molloy EJ. Cardiac biomarkers in neonatal hypoxic ischaemia. Acta Paediatr 2012; 101 (04) 338-343
  • 20 Vafaie M, Biener M, Mueller M. et al. Analytically false or true positive elevations of high sensitivity cardiac troponin: a systematic approach. Heart 2014; 100 (06) 508-514